J.H. studied Chemistry at the University of Rostock, Germany and held a PhD of Pharmaceutical Chemistry of the University of Vienna. He works since over 25 years for Baxter/Baxalta/Shire and now for Takeda in different functions in Manufacturing and R&D. Currently he is acting as head of formulation development for plasma-derived therapy (PDT) products.